Annual CFF
$1.65 M
-$12.04 M-87.96%
March 1, 2024
Summary
- As of February 26, 2025, VRAX annual cash flow from financing activities is $1.65 million, with the most recent change of -$12.04 million (-87.96%) on March 1, 2024.
- During the last 3 years, VRAX annual CFF has risen by +$1.06 million (+181.65%).
- VRAX annual CFF is now -87.96% below its all-time high of $13.69 million, reached on March 31, 2023.
Performance
VRAX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VRAX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.0% | - | - |
| 3 y3 years | +181.7% | - | - |
| 5 y5 years | +133.9% | - | - |
VRAX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.0% | +181.7% | ||||
| 5 y | 5-year | -88.0% | +181.7% | ||||
| alltime | all time | -88.0% | +181.7% |
Virax Biolabs Group Limited Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $1.65 M(-88.0%) | - | - |
| Mar 2023 | $13.69 M(+1583.3%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | $813.20 K(+39.0%) | - | - |
| Mar 2021 | $585.20 K(-16.9%) | - | - |
| Mar 2020 | $704.60 K | - | - |
FAQ
- What is Virax Biolabs Group Limited annual cash flow from financing activities?
- What is the all time high annual CFF for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual CFF year-on-year change?
What is Virax Biolabs Group Limited annual cash flow from financing activities?
The current annual CFF of VRAX is $1.65 M
What is the all time high annual CFF for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual cash flow from financing activities is $13.69 M
What is Virax Biolabs Group Limited annual CFF year-on-year change?
Over the past year, VRAX annual cash flow from financing activities has changed by -$12.04 M (-87.96%)